Previous Article | Next Article 
Infection and Immunity, June 2000, p. 3635-3641, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Production of Basic Fibroblast Growth Factor and
Interleukin 6 by Human Smooth Muscle Cells following Infection
with Chlamydia pneumoniae
Jürgen
Rödel,*
Marcus
Woytas,
Annemarie
Groh,
Karl-Hermann
Schmidt,
Matthias
Hartmann,
Marc
Lehmann, and
Eberhard
Straube
Institute of Medical Microbiology, Friedrich
Schiller University of Jena, D-07740 Jena, Germany
Received 29 November 1999/Returned for modification 7 January
2000/Accepted 15 March 2000
Chlamydia pneumoniae infection has been associated with
asthma and atherosclerosis. Smooth muscle cells represent host cells for chlamydiae during chronic infection. In this study we demonstrated that C. pneumoniae infection of human smooth muscle cells
in vitro increased production of interleukin 6 (IL-6) and basic
fibroblast growth factor (bFGF) as shown by reverse transcription-PCR,
immunoblotting, and enzyme-linked immunosorbent assay. In contrast,
levels of platelet-derived growth factor A-chain mRNA were not affected after infection. The stimulation of bFGF and IL-6 production was most
effective when viable chlamydiae were used as inoculum. Furthermore, inhibition of bacterial protein synthesis with chloramphenicol prevented up-regulation of IL-6 and bFGF in infected cells. Addition of
IL-6 antibody to infected cultures diminished bFGF expression, indicating involvement of produced IL-6. These findings suggest that
chlamydial infection of smooth muscle cells elicits a cytokine response
that may contribute to structural remodeling of the airway wall in
chronic asthma and to fibrous plaque formation in atherosclerosis.
*
Corresponding author. Mailing address: Institute of
Medical Microbiology, Friedrich Schiller University of Jena,
Semmelweisstr. 4, D-07740 Jena, Germany. Phone: 49-3641-933105. Fax: 49-3641-933474. E-mail:
Roedel{at}bach.med.uni-jena.de.
Infection and Immunity, June 2000, p. 3635-3641, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Baumert, J., Schmidt, K.-H., Eitner, A., Straube, E., Rodel, J.
(2009). Host Cell Cytokines Induced by Chlamydia pneumoniae Decrease the Expression of Interstitial Collagens and Fibronectin in Fibroblasts. Infect. Immun.
77: 867-876
[Abstract]
[Full Text]
-
Bobryshev, Y. V., Lord, R. S. A., Tran, D.
(2006). Chlamydia pneumoniae in foci of "early" calcification of the tunica media in arteriosclerotic arteries: an incidental presence?. Am. J. Physiol. Heart Circ. Physiol.
290: H1510-H1519
[Abstract]
[Full Text]
-
Johnston, S. C., Zhang, H., Messina, L. M., Lawton, M. T., Dean, D.
(2005). Chlamydia pneumoniae Burden in Carotid Arteries Is Associated With Upregulation of Plaque Interleukin-6 and Elevated C-Reactive Protein in Serum. Arterioscler. Thromb. Vasc. Bio.
25: 2648-2653
[Abstract]
[Full Text]
-
Johnston, S. L., Martin, R. J.
(2005). Chlamydophila pneumoniae and Mycoplasma pneumoniae: A Role in Asthma Pathogenesis?. Am. J. Respir. Crit. Care Med.
172: 1078-1089
[Abstract]
[Full Text]
-
Rodel, J., Prochnau, D., Prager, K., Baumert, J., Schmidt, K.-H., Straube, E.
(2004). Chlamydia pneumoniae Decreases Smooth Muscle Cell Proliferation through Induction of Prostaglandin E2 Synthesis. Infect. Immun.
72: 4900-4904
[Abstract]
[Full Text]
-
Sander, D., Winbeck, K., Klingelhofer, J., Etgen, T., Conrad, B.
(2004). Progression of Early Carotid Atherosclerosis Is Only Temporarily Reduced After Antibiotic Treatment of Chlamydia pneumoniae Seropositivity. Circulation
109: 1010-1015
[Abstract]
[Full Text]
-
Yang, J., Hooper, W. C., Phillips, D. J., Tondella, M. L., Talkington, D. F.
(2003). Induction of Proinflammatory Cytokines in Human Lung Epithelial Cells during Chlamydia pneumoniae Infection. Infect. Immun.
71: 614-620
[Abstract]
[Full Text]
-
Sander, D., Winbeck, K., Klingelhofer, J., Etgen, T., Conrad, B.
(2002). Reduced Progression of Early Carotid Atherosclerosis After Antibiotic Treatment and Chlamydia pneumoniae Seropositivity. Circulation
106: 2428-2433
[Abstract]
[Full Text]
-
Tiran, A., Gruber, H.-J., Graier, W. F., Wagner, A. H., van Leeuwen, E. B.M., Tiran, B.
(2002). Aspirin Inhibits Chlamydia pneumoniae-Induced Nuclear Factor-{kappa}B Activation, Cytokine Expression, and Bacterial Development in Human Endothelial Cells. Arterioscler. Thromb. Vasc. Bio.
22: 1075-1080
[Abstract]
[Full Text]
-
Hermann, C., Graf, K., Groh, A., Straube, E., Hartung, T.
(2002). Comparison of Eleven Commercial Tests for Chlamydia pneumoniae-Specific Immunoglobulin G in Asymptomatic Healthy Individuals. J. Clin. Microbiol.
40: 1603-1609
[Abstract]
[Full Text]
-
Tavendale, R., Parratt, D., Pringle, S.D., A'brook, R., Tunstall-Pedoe, H.
(2002). Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events. The Scottish Heart Health Study Cohort. Eur Heart J
23: 301-307
[Abstract]
[Full Text]
-
Johnston, S. C., Messina, L. M., Browner, W. S., Lawton, M. T., Morris, C., Dean, D.
(2001). C-Reactive Protein Levels and Viable Chlamydia pneumoniae in Carotid Artery Atherosclerosis. Stroke
32: 2748-2752
[Abstract]
[Full Text]
-
Kroegel, C., Rodel, J., Mock, B., Garey, K. W., Rubinstein, I.
(2001). Chlamydia pneumoniae, Clarithromycin, and Severe Asthma. Chest
120: 1035-1036
[Full Text]
-
Coombes, B. K., Mahony, J. B.
(2001). cDNA Array Analysis of Altered Gene Expression in Human Endothelial Cells in Response to Chlamydia pneumoniae Infection. Infect. Immun.
69: 1420-1427
[Abstract]
[Full Text]